INS and diabetes mellitus: This underscores the potential of CPCM as a therapeutic strategy for improving metabolic health, as elevated SCFAs are linked to better insulin sensitivity and glucose management—critical factors in diabetes management and complication prevention (Xiong et al., 2022).